Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,222,645
  • Shares Outstanding, K 296,199
  • Annual Sales, $ 399,360 K
  • Annual Income, $ -151,580 K
  • 60-Month Beta 0.69
  • Price/Sales 8.33
  • Price/Cash Flow N/A
  • Price/Book 25.11
Trade FOLD with:

Options Overview Details

View History
  • Implied Volatility 72.37% ( +33.24%)
  • Historical Volatility 26.45%
  • IV Percentile 94%
  • IV Rank 67.81%
  • IV High 99.87% on 07/18/24
  • IV Low 14.43% on 06/21/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 82
  • Volume Avg (30-Day) 343
  • Put/Call OI Ratio 1.41
  • Today's Open Interest 19,655
  • Open Int (30-Day) 33,401

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.01
  • Number of Estimates 6
  • High Estimate 0.05
  • Low Estimate -0.02
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +114.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.44 +2.68%
on 09/26/24
11.98 -10.55%
on 09/03/24
-0.93 (-7.98%)
since 08/26/24
3-Month
9.35 +14.59%
on 08/05/24
12.19 -12.06%
on 08/21/24
+1.02 (+10.52%)
since 06/26/24
52-Week
9.02 +18.85%
on 05/13/24
14.57 -26.42%
on 12/28/23
-1.52 (-12.42%)
since 09/26/23

Most Recent Stories

More News
Amicus Therapeutics: Q2 Earnings Snapshot

Amicus Therapeutics: Q2 Earnings Snapshot

FOLD : 10.72 (-1.47%)
Stock Index Futures Tread Water Ahead of Key U.S. PPI Data and Powell Remarks

June S&P 500 E-Mini futures (ESM24) are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.03% this morning as investors geared up for crucial U.S. producer inflation data while also awaiting...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
INCY : 65.13 (+3.02%)
INTC : 23.92 (+1.61%)
SQSP : 46.41 (+0.06%)
AMAT : 209.61 (+6.23%)
HD : 396.70 (-0.06%)
ALC.Z.IX : 83.820 (+0.17%)
DHER.D.DX : 35.120 (+4.68%)
RHM.D.DX : 484.900 (-1.56%)
FULC : 4.00 (+15.27%)
FOLD : 10.72 (-1.47%)
Amicus Therapeutics: Q1 Earnings Snapshot

Amicus Therapeutics: Q1 Earnings Snapshot

FOLD : 10.72 (-1.47%)
2 ‘Strong-Buy’-Rated Stocks With Around 50% Upside

Wall Street predicts that these rapidly expanding growth stocks will generate outsized gains this year.

$SPX : 5,745.37 (+0.40%)
$NASX : 18,190.29 (+0.60%)
CVE : 16.29 (-4.18%)
FOLD : 10.72 (-1.47%)
NGG24 : 2.490s (-8.19%)
Amicus Therapeutics: Q3 Earnings Snapshot

Amicus Therapeutics: Q3 Earnings Snapshot

FOLD : 10.72 (-1.47%)
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates...

FOLD : 10.72 (-1.47%)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023

Stocks that traded heavily or had substantial price changes on Friday: Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall

OPK : 1.4900 (+0.68%)
MTN : 187.95 (+2.84%)
FOLD : 10.72 (-1.47%)
BLK : 945.02 (+0.88%)
NKE : 89.39 (+1.58%)
WuXi Biologics Reports Solid 2023 Interim Results

Revenue Increased by 17.8% Y-o-Y to RMB8,492.0 Million Adjusted Net Profit Rose by 0.4% to RMB2,925.6 Million Non-COVID Revenue Achieved 59.7% Y-o-Y Growth,...

FOLD : 10.72 (-1.47%)
Amicus Therapeutics: Q2 Earnings Snapshot

Amicus Therapeutics: Q2 Earnings Snapshot

FOLD : 10.72 (-1.47%)
Amicus Therapeutics: Q1 Earnings Snapshot

Amicus Therapeutics: Q1 Earnings Snapshot

FOLD : 10.72 (-1.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Amicus Therapeutics, Inc. is a global patient-centric biotechnology company engaged in the discovery, development and commercialization of a diverse set of novel treatments for patients living with rare metabolic diseases.'The company has one marketed medicine in its portfolio named Galafold which is...

See More

Key Turning Points

3rd Resistance Point 11.58
2nd Resistance Point 11.29
1st Resistance Point 11.01
Last Price 10.72
1st Support Level 10.44
2nd Support Level 10.15
3rd Support Level 9.87

See More

52-Week High 14.57
Fibonacci 61.8% 12.45
Fibonacci 50% 11.80
Fibonacci 38.2% 11.14
Last Price 10.72
52-Week Low 9.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar